Skip to content

Non-cash lease expense at other companies

BioLife Solutions logo
BioLife SolutionsBLFS
$468.75K+342%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$550K+41.0%
GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$962K+1.1%
Central Pacific Financial logo
Central Pacific FinancialCPF
$0-100%
Flotek Industries logo
Flotek IndustriesFTK
$188K-40.9%
Hamilton Lane logo
Hamilton LaneHLNE
$2.45M+1.9%

Other financials

Income statement

See full
Revenue$46.3M+44.7%
Gross profit$23.6M+23.2%
Operating income-$8.5M+41.1%
Net income-$5.0M-197%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$56.1M+124%
Total debt$42.0M+191%
Total equity$120.7M-0.3%
Total assets$304.6M+19.0%

Cash flow

See full
Operating cash flow-$3.2M-25.2%
CapEx$6.4M+107%
Free cash flow-$9.6M-70.0%

Valuation

See full
Market cap$987.49M+5.1%
Enterprise value$973.38M+4.8%
P/S6.2×-2.1×

Profitability

See full
Gross margin49.8%-8.7pp
Operating margin-26.6%-9.9pp
Net margin-43.8%-8.7pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-51.7%+24.4pp
Debt / equity0.3×+0.2×
Current ratio1.2×+0.1×

Where this comes from

Reported directly by Evolv Technologies Holdings, Inc. in its filing.

Tagged under the XBRL concept evlv:NoncashLeaseExpense.

The official record: Evolv Technologies Holdings, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolv Technologies Holdings, Inc.'s non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolv Technologies Holdings, Inc.'s non-cash lease expense?
Evolv Technologies Holdings, Inc. (EVLV) reported non-cash lease expense of $432K in Q1 2026.
How has Evolv Technologies Holdings, Inc.'s non-cash lease expense changed year-over-year?
Evolv Technologies Holdings, Inc.'s non-cash lease expense increased by 1.9% year-over-year, from $424K to $432K.
What does non-cash lease expense mean?
Represents the portion of lease costs recognized as an expense that does not correspond to a cash payment, typically associated with the amortization of right-of-use assets. This metric is essential for reconciling GAAP operating expenses with actual cash outflows related to real estate or equipment leasing.